Both in Pharmaceuticals
Pyxis Oncology vs Spruce Biosciences
Over the past year PYXS returned −51.4% and SPRB returned −66.1%; their daily moves had a correlation of 0.10.
PYXS −51.4% SPRB −66.1%Growth of $1, one year, split-adjusted
| Metric | PYXS | SPRB |
|---|---|---|
| Price | $1.68 | $45.15 |
| Market cap | $140.1M | $129.8M |
| Today | −1.75% | −1.85% |
| 1 month | −42.5% | −7.9% |
| 6 months | −11.6% | −17.0% |
| Year to date | +46.1% | −48.2% |
| 1 year | −51.9% | −67.9% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 12.7× | — |
| Net cash | $33.0M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 120.5% | 64.2% |
| Short % of float | 8.8% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).